Vivoryon Therapeutics N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 29 mei 2015 - 08:00

Statutaire naam Vivoryon Therapeutics N.V.

Titel Probiodrug to present at the Jefferies Healthcare Conference and BIO International Convention

Bericht HALLE/SAALE, Germany, 29 May 2015 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease, announces that Dr Konrad Glund, CEO of Probiodrug, is scheduled to present at the following events:

Vorige register resultaat

Volgende register resultaat

Gerelateerde downloads

201505290000000004_Probiodrug to present at the Jefferies Healthcare Conference and BIO International Convention.pdf (opens in a new window)

Datum laatste update: 01 september 2024